Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Moxifloxacin bulk supplier for pharma manufacturers

Moxifloxacin Suppliers & Bulk Manufacturers

Available Forms: yellow to yellowish crystalline powder

Available Strengths: Assay: 98.0% – 102.0% (USP/BP Standard)

Reference Brands:

Category: Active Pharmaceutical Ingredient

Moxifloxacin is effective for the treatment of respiratory tract infections including acute exacerbations of chronic bronchitis, community-acquired pneumonia, and acute bacterial sinusitis. It is also indicated for the treatment of uncomplicated skin and skin structure infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Moxifloxacin Hydrochloride is a broad-spectrum fluoroquinolone antibiotic used for the treatment of various bacterial infections. It inhibits bacterial DNA gyrase and topoisomerase IV, leading to the death of susceptible bacteria. This API is widely used in the manufacturing of oral tablets, ophthalmic solutions, and injectable formulations.

Moxifloxacin — third party manufacturing & bulk supply

Moxifloxacin is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Moxifloxacin is supplied as yellow to yellowish crystalline powder — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Moxifloxacin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Moxifloxacin →
Back to Listing

Frequently Asked Questions

Moxifloxacin is listed as yellow to yellowish crystalline powder in Assay: 98.0% – 102.0% (USP/BP Standard). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Related Products

Ketoconazole Api

Strength:
High-purity powder with assay typically 98% or higher (USP / EP / BP)

Form: White to off-white crystalline powder

Reference Brands: Nizoral (US/EU)

View Details
Restoril ( Temazepam Api )

Strength:
High-purity API (≥99% Temazepam content)

Form: crystalline powder with no significant odor

Reference Brands:

View Details
Clotrimazole

Strength:
High-purity powder with assay typically 98% or higher (USP / EP / BP)

Form: Granules/ Powder

Reference Brands: Canesten (EU), Lotrimin (US)

View Details
Epinephrine

Strength:
High-purity crystalline API, 98% purity (USP Standard)

Form: Crystalline powder

Reference Brands: EpiPen, Adrenalin (US)

View Details
Calcium Dobesilate Granules

Strength:
API Purity: 98% (on anhydrous basis)

Form: Granules/ Powder

Reference Brands:

View Details
Isavuconazole

Strength:
High-purity API

Form: White to off-white crystalline powder

Reference Brands: Cresemba (US/EU)

View Details
Levocarnitine Api

Strength:
API Purity: 98% (on anhydrous basis) BP / EP / USP Standard

Form: Crystalline powder

Reference Brands: Carnitor (US/EU)

View Details
Doxepin

Strength:
API Purity: 99% (on anhydrous basis)

Form: White to off-white crystalline powder

Reference Brands: Sinequan, Silenor (US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.